Aceragen Announces $3.5 Million Development Award from Cystic Fibrosis Foundation to Progress Novel Therapy for CF-Related Exacerbations
06 janv. 2022 09h00 HE
|
Aceragen
Raleigh-Durhan, NC, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Aceragen, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for orphan diseases with high unmet medical need, today...
Aceragen’s wholly-owned subsidiary, Arrevus, awarded $45 million funding agreement from the Department of Defense’s Defense Threat Reduction Agency for Development of ACG-701 as Medical Countermeasure Against Melioidosis
05 janv. 2022 09h00 HE
|
Aceragen
Raleigh-Durham, NC, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Arrevus, Inc., a clinical-stage biopharmaceutical company developing therapies for orphan infectious diseases with high unmet medical need, ...
Insights on Pharma, Biotech & Diagnostics Industry from 2015 to 2021
10 nov. 2021 04h03 HE
|
Research and Markets
Dublin, Nov. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2015-2021" report has been added to ResearchAndMarkets.com's...
ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
09 août 2021 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021...
ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
30 mars 2021 17h10 HE
|
ProPhase Labs, Inc.
New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events GARDEN CITY, NY, March...
ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
15 mars 2021 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021...
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
29 janv. 2021 08h30 HE
|
ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...